Berkhout B - Search Results

1

A highly virulent variant of HIV-1 circulating in the Netherlands.

Wymant C, Bezemer D, Blanquart F, Ferretti L, Gall A, Hall M, Golubchik T, Bakker M, Ong SH, Zhao L, Bonsall D, de Cesare M, MacIntyre-Cockett G, Abeler-Dörner L, Albert J, Bannert N, Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C; Netherlands ATHENA HIV Observational Cohort†; BEEHIVE Collaboration†. Wymant C, et al. Among authors: berkhout b. Science. 2022 Feb 4;375(6580):540-545. doi: 10.1126/science.abk1688. Epub 2022 Feb 3. Science. 2022. PMID: 35113714 Free article.

2

Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR.

Gatignol A, Buckler-White A, Berkhout B, Jeang KT. Gatignol A, et al. Among authors: berkhout b. Science. 1991 Mar 29;251(5001):1597-600. doi: 10.1126/science.2011739. Science. 1991. PMID: 2011739

3

Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

Back NK, Nijhuis M, Keulen W, Boucher CA, Oude Essink BO, van Kuilenburg AB, van Gennip AH, Berkhout B. Back NK, et al. Among authors: berkhout b. EMBO J. 1996 Aug 1;15(15):4040-9. EMBO J. 1996. PMID: 8670908 Free PMC article.

4

Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins.

Keulen W, Boucher C, Berkhout B. Keulen W, et al. Among authors: berkhout b. Antiviral Res. 1996 Jun;31(1-2):45-57. doi: 10.1016/0166-3542(96)00944-8. Antiviral Res. 1996. PMID: 8793008

5

Reverse transcriptase fidelity and HIV-1 variation.

Keulen W, Nijhuis M, Schuurman R, Berkhout B, Boucher C. Keulen W, et al. Among authors: berkhout b. Science. 1997 Jan 10;275(5297):229; author reply 230-1. Science. 1997. PMID: 8999550 No abstract available.

6

Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase.

Keulen W, Back NK, van Wijk A, Boucher CA, Berkhout B. Keulen W, et al. Among authors: berkhout b. J Virol. 1997 Apr;71(4):3346-50. doi: 10.1128/JVI.71.4.3346-3350.1997. J Virol. 1997. PMID: 9060708 Free PMC article.

7

Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase.

Oude Essink BB, Back NK, Berkhout B. Oude Essink BB, et al. Among authors: berkhout b. Nucleic Acids Res. 1997 Aug 15;25(16):3212-7. doi: 10.1093/nar/25.16.3212. Nucleic Acids Res. 1997. PMID: 9241233 Free PMC article.

8

Structural and functional analysis of negatively charged milk proteins with anti-HIV activity.

Berkhout B, Derksen GC, Back NK, Klaver B, de Kruif CG, Visser S. Berkhout B, et al. AIDS Res Hum Retroviruses. 1997 Sep 1;13(13):1101-7. doi: 10.1089/aid.1997.13.1101. AIDS Res Hum Retroviruses. 1997. PMID: 9282815

9

Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.

Back NK, Berkhout B. Back NK, et al. Among authors: berkhout b. Antimicrob Agents Chemother. 1997 Nov;41(11):2484-91. doi: 10.1128/AAC.41.11.2484. Antimicrob Agents Chemother. 1997. PMID: 9371354 Free PMC article.

10

Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains.

Berkhout B, Verhoef K, van Wamel JL, Back NK. Berkhout B, et al. J Virol. 1999 Feb;73(2):1138-45. doi: 10.1128/JVI.73.2.1138-1145.1999. J Virol. 1999. PMID: 9882315 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

603 results

Search Page

Filters